---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-031331"
form_type: "8-K"
ticker: null
cik: "0001213660"
company_name: "BIMI Holdings Inc."
filed_at: "2023-04-20T23:59:59+00:00"
generated_at: "2026-06-16T22:16:44.984689+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIMI receives Nasdaq deficiency notices for late 10-K and bid price below $1

## Summary
- Received Nasdaq notice on Apr 18, 2023 for failing to file FY2022 10-K by deadline per Listing Rule 5250(c)(1).
- Received separate bid price deficiency notice on Apr 19, 2023; closing bid below $1.00 for 30 consecutive days.
- Company has 60 days to submit compliance plan for 10-K; possible 180-day extension if plan accepted.
- For bid price, compliance period runs until Oct 16, 2023; can be cured by 10 consecutive days at $1.00+.
- Shares continue trading on Nasdaq Capital Market under symbol BIMI while company evaluates options.

## SEC filing metadata
- accession: 0001213900-23-031331
- form_type: 8-K
- cik: 0001213660
- company_name: BIMI Holdings Inc.
- filed_at: 2023-04-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213660/000121390023031331/0001213900-23-031331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213660/000121390023031331/ea177164-8k_bimiinter.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-031331
- JSON: https://secwatch.observer/filing/0001213900-23-031331.json
- Plain text: https://secwatch.observer/filing/0001213900-23-031331.txt

## Key facts
- Listing & Compliance Notices
  BIMI Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 19, 2023, the Company received a deficiency letter (the “Nasdaq Bid Price Deficiency Letter”) from Nasdaq notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The Nasdaq Bid Price Deficiency Letter has no immediate effect on the listing of the Company’s common stock, and its common stock will continue to trade on The Nasdaq Capital Market under the symbol “BIMI” at this tim
  evidence_url: https://www.sec.gov/Archives/edgar/data/1213660/000121390023031331/0001213900-23-031331-index.htm
- Listing & Compliance Notices
  BIMI Holdings Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: April 18, 2023, BIMI International Medical Inc. (the “Company”) received a notification letter (the “Nasdaq 10K Delinquency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2022 (the “Form 10-K”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq 10K Delinquency Letter states that the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1213660/000121390023031331/0001213900-23-031331-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.